tiprankstipranks
Trending News
More News >
Avecho Biotechnology Limited (AU:AVE)
ASX:AVE
Australian Market

Avecho Biotechnology Limited (AVE) Financial Statements

Compare
7 Followers

Avecho Biotechnology Limited Financial Overview

Avecho Biotechnology Limited's market cap is currently AU$12.69M. The company's EPS TTM is AU$-0.001; its P/E ratio is ―; Avecho Biotechnology Limited is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueAU$ 1.13MAU$ 473.55KAU$ 1.13MAU$ 793.60KAU$ 384.63K
Gross ProfitAU$ 671.93KAU$ -43.80KAU$ 793.12KAU$ 507.94KAU$ 240.91K
Operating IncomeAU$ -4.96MAU$ -4.59MAU$ -3.06MAU$ -4.55MAU$ -3.39M
EBITDAAU$ -2.92MAU$ -3.24MAU$ -2.11MAU$ -2.98MAU$ -2.28M
Net IncomeAU$ -3.12MAU$ -3.44MAU$ -2.34MAU$ -3.42MAU$ -2.63M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 2.37MAU$ 5.50MAU$ 1.47MAU$ 3.26MAU$ 1.87M
Total AssetsAU$ 5.00MAU$ 7.32MAU$ 3.35MAU$ 5.25MAU$ 3.35M
Total DebtAU$ 1.08MAU$ 175.15KAU$ 246.07KAU$ 93.91KAU$ 166.23K
Net DebtAU$ -1.30MAU$ -5.33MAU$ -1.22MAU$ -3.17MAU$ -1.71M
Total LiabilitiesAU$ 1.73MAU$ 941.54KAU$ 920.66KAU$ 709.36KAU$ 700.17K
Stockholders' EquityAU$ 3.27MAU$ 6.38MAU$ 2.42MAU$ 4.54MAU$ 2.65M
Cash Flow
Free Cash FlowAU$ -3.97MAU$ -3.18MAU$ -1.72MAU$ -3.30MAU$ -1.43M
Operating Cash FlowAU$ -3.97MAU$ -3.18MAU$ -1.67MAU$ -3.10MAU$ -1.42M
Investing Cash Flow-AU$ 0.00AU$ -53.12KAU$ -202.82KAU$ -5.15K
Financing Cash FlowAU$ 854.59KAU$ 7.22MAU$ -78.22KAU$ 4.69MAU$ -82.50K
Currency in AUD

Avecho Biotechnology Limited Earnings and Revenue History

Avecho Biotechnology Limited Debt to Assets

Avecho Biotechnology Limited Cash Flow

Avecho Biotechnology Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis